Two CLL Couples Connect: Our Shared Experiences
Patient Power Founder Andrew Schorr was treated at MD Anderson Cancer Center more than 17 years ago with FCR (fludarabine, cyclophosphamide, rituximab)... Learn More
Day
August 5, 2017